Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.29 | N/A |
| PEG Ratio (TTM) | -15.68 | N/A |
| P/S Ratio (TTM) | 0.30 | N/A |
| P/B Ratio (TTM) | 3.49 | N/A |
| P/FCF Ratio (TTM) | 20.42 | N/A |
| Price to 5YR AVG Earnings Ratio | 22.61 | N/A |
| Price to 5YR AVG FCF Ratio | 17.11 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.43% | N/A |
| ROE (TTM) | 22.38% | N/A |
| Net Profit Margin (TTM) | 1.85% | N/A |
| ROIC 5YR AVG | 10.89% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 6.03% | -6.23% | 3.74% |
| Revenue | 1.35% | 4.45% | 4.41% |
| Net Income | 6.11% | -8.94% | 1.04% |
| Cash Flow | 59.04% | 16.32% | 15.21% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.54 | N/A |
| Quick Ratio (TTM) | 1.07 | N/A |
| D/E Ratio (TTM) | 1.60 | N/A |
| Interest Coverage (TTM) | 11.48 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.96 | N/A |
| LTL to 5YR AVG FCF | 6.97 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.37% | N/A |